Loading
A phase 2 trial in pancreatic cancer, run by Yonsei University, now recruiting.
Preoperative Stereotactic Body Radiation Therapy in Patients With Resectable Pancreatic Cancer is a phase 2, interventional study registered as NCT05679583 by Yonsei University, with a registry enrolment figure of 25 participants, started 2022-09-26 and due to reach its primary completion in 2026-09-25. Interventions recorded: Preoperative Stereotactic body radiation therapy (SBRT), Pancreatic resection, Adjuvant Chemotherapy. Conditions listed: Pancreatic Cancer. Primary outcome: R0 rate. Pancreatic eligibility wording from the registry: "Histologically diagnosed adenocarcinoma of the pancreas". Sites: South Korea. No results are recorded here; the registry entry is the source.
Shares SBRT / SABR (stereotactic radiotherapy), Resectable pancreatic ductal adenocarcinoma, Pancreatic cancer trials open today (registry snapshot and UK sites) and the tag pancreatic-deep-dive.
Shares Resectable pancreatic ductal adenocarcinoma, Pancreatic cancer trials open today (registry snapshot and UK sites) and the tag pancreatic-deep-dive.
Shares Resectable pancreatic ductal adenocarcinoma, Pancreatic cancer trials open today (registry snapshot and UK sites) and the tag pancreatic-deep-dive.
Shares Resectable pancreatic ductal adenocarcinoma, Pancreatic cancer trials open today (registry snapshot and UK sites) and the tag pancreatic-deep-dive.
Shares Resectable pancreatic ductal adenocarcinoma, Pancreatic cancer trials open today (registry snapshot and UK sites) and the tag pancreatic-deep-dive.
Shares Resectable pancreatic ductal adenocarcinoma, Pancreatic cancer trials open today (registry snapshot and UK sites) and the tag pancreatic-deep-dive.
Shares Resectable pancreatic ductal adenocarcinoma, Pancreatic cancer trials open today (registry snapshot and UK sites) and the tag pancreatic-deep-dive.
Shares Resectable pancreatic ductal adenocarcinoma, Pancreatic cancer trials open today (registry snapshot and UK sites) and the tag pancreatic-deep-dive.